Xvivo Perfusion AB
XVIVO.ST
#5119
Rank
S$1.71 B
Marketcap
$54.37
Share price
-0.22%
Change (1 day)
66.46%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): S$15.55 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are S$65.99 Million. In 2023 the company made an earning of S$12.62 Million, an increase over its 2022 earnings that were of S$3.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$15.55 M23.21%
2023 S$12.62 M309.49%
2022 S$3.08 M226.49%
2021 S$0.94 M-110.72%
2020 -S$8.81 Million-1221.07%
2019 S$0.78 M-70.61%
2018 S$2.67 M117.32%
2017 S$1.22 M146.09%
2016 S$0.49 M-61.52%
2015 S$1.29 M-3.88%
2014 S$1.35 M-39.59%
2013 S$2.23 M